183 related articles for article (PubMed ID: 38927459)
1. Synthesis and Characterization of Click Chemical Probes for Single-Cell Resolution Detection of Epichaperomes in Neurodegenerative Disorders.
Bay S; Digwal CS; Rodilla Martín AM; Sharma S; Stanisavljevic A; Rodina A; Attaran A; Roychowdhury T; Parikh K; Toth E; Panchal P; Rosiek E; Pasala C; Arancio O; Fraser PE; Alldred MJ; Prado MAM; Ginsberg SD; Chiosis G
Biomedicines; 2024 Jun; 12(6):. PubMed ID: 38927459
[TBL] [Abstract][Full Text] [Related]
2. Chemical probes and methods for single-cell detection and quantification of epichaperomes in hematologic malignancies.
Merugu S; Sharma S; Kaner J; Digwal C; Sugita M; Joshi S; Taldone T; Guzman ML; Chiosis G
Methods Enzymol; 2020; 639():289-311. PubMed ID: 32475406
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the Mechanism of Epichaperome Modulation by Zelavespib: Biochemical Insights on Target Occupancy and Extended Residence Time at the Site of Action.
Sharma S; Joshi S; Kalidindi T; Digwal CS; Panchal P; Lee SG; Zanzonico P; Pillarsetty N; Chiosis G
Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37892973
[TBL] [Abstract][Full Text] [Related]
4. Safety, Tolerability and Pharmacokinetics of Icapamespib, a Selective Epichaperome Inhibitor, in Healthy Adults.
Silverman MH; Duggan S; Bardelli G; Sadler B; Key C; Medlock M; Reynolds L; Wallner B
J Prev Alzheimers Dis; 2022; 9(4):635-645. PubMed ID: 36281667
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of
Sharma S; Kalidindi T; Joshi S; Digwal CS; Panchal P; Burnazi E; Lee SG; Pillarsetty N; Chiosis G
STAR Protoc; 2022 Jun; 3(2):101318. PubMed ID: 35496791
[TBL] [Abstract][Full Text] [Related]
6. Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system.
Bolaender A; Zatorska D; He H; Joshi S; Sharma S; Digwal CS; Patel HJ; Sun W; Imber BS; Ochiana SO; Patel MR; Shrestha L; Shah SK; Wang S; Karimov R; Tao H; Patel PD; Martin AR; Yan P; Panchal P; Almodovar J; Corben A; Rimner A; Ginsberg SD; Lyashchenko S; Burnazi E; Ku A; Kalidindi T; Lee SG; Grkovski M; Beattie BJ; Zanzonico P; Lewis JS; Larson S; Rodina A; Pillarsetty N; Tabar V; Dunphy MP; Taldone T; Shimizu F; Chiosis G
Nat Commun; 2021 Aug; 12(1):4669. PubMed ID: 34344873
[TBL] [Abstract][Full Text] [Related]
7. Use of Native-PAGE for the Identification of Epichaperomes in Cell Lines.
Roychowdhury T; Santhaseela AR; Sharma S; Panchal P; Rodina A; Chiosis G
Methods Mol Biol; 2023; 2693():175-191. PubMed ID: 37540435
[TBL] [Abstract][Full Text] [Related]
8. Targeting stressor-induced dysfunctions in protein-protein interaction networks via epichaperomes.
Ginsberg SD; Sharma S; Norton L; Chiosis G
Trends Pharmacol Sci; 2023 Jan; 44(1):20-33. PubMed ID: 36414432
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation-Driven Epichaperome Assembly: A Critical Regulator of Cellular Adaptability and Proliferation.
McNutt SW; Roychowdhury T; Pasala C; Nguyen HT; Thornton DT; Sharma S; Botticelli L; Digwal CS; Joshi S; Yang N; Panchal P; Chakrabarty S; Bay S; Markov V; Kwong C; Lisanti J; Chung SY; Ginsberg SD; Yan P; DeStanchina E; Corben A; Modi S; Alpaugh M; Colombo G; Erdjument-Bromage H; Neubert TA; Chalkley RJ; Baker PR; Burlingame AL; Rodina A; Chiosis G; Chu F
Res Sq; 2024 Apr; ():. PubMed ID: 38645031
[TBL] [Abstract][Full Text] [Related]
10. The penalty of stress - Epichaperomes negatively reshaping the brain in neurodegenerative disorders.
Ginsberg SD; Joshi S; Sharma S; Guzman G; Wang T; Arancio O; Chiosis G
J Neurochem; 2021 Dec; 159(6):958-979. PubMed ID: 34657288
[TBL] [Abstract][Full Text] [Related]
11. Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells.
Carter BZ; Mak PY; Muftuoglu M; Tao W; Ke B; Pei J; Bedoy AD; Ostermann LB; Nishida Y; Isgandarova S; Sobieski M; Nguyen N; Powell RT; Martinez-Moczygemba M; Stephan C; Basyal M; Pemmaraju N; Boettcher S; Ebert BL; Shpall EJ; Wallner B; Morgan RA; Karras GI; Moll UM; Andreeff M
Blood; 2023 Sep; 142(12):1056-1070. PubMed ID: 37339579
[TBL] [Abstract][Full Text] [Related]
12. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
[TBL] [Abstract][Full Text] [Related]
13. The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction.
Inda MC; Joshi S; Wang T; Bolaender A; Gandu S; Koren Iii J; Che AY; Taldone T; Yan P; Sun W; Uddin M; Panchal P; Riolo M; Shah S; Barlas A; Xu K; Chan LYL; Gruzinova A; Kishinevsky S; Studer L; Fossati V; Noggle SA; White JR; de Stanchina E; Sequeira S; Anthoney KH; Steele JW; Manova-Todorova K; Patil S; Dunphy MP; Pillarsetty N; Pereira AC; Erdjument-Bromage H; Neubert TA; Rodina A; Ginsberg SD; De Marco Garcia N; Luo W; Chiosis G
Nat Commun; 2020 Jan; 11(1):319. PubMed ID: 31949159
[TBL] [Abstract][Full Text] [Related]
14. First-in-Human Trial of Epichaperome-Targeted PET in Patients with Cancer.
Dunphy MPS; Pressl C; Pillarsetty N; Grkovski M; Modi S; Jhaveri K; Norton L; Beattie BJ; Zanzonico PB; Zatorska D; Taldone T; Ochiana SO; Uddin MM; Burnazi EM; Lyashchenko SK; Hudis CA; Bromberg J; Schöder HM; Fox JJ; Zhang H; Chiosis G; Lewis JS; Larson SM
Clin Cancer Res; 2020 Oct; 26(19):5178-5187. PubMed ID: 32366671
[TBL] [Abstract][Full Text] [Related]
15. Early Diagnosis of Neurodegenerative Diseases: What Has Been Undertaken to Promote the Transition from PET to Fluorescence Tracers.
Bisi N; Pinzi L; Rastelli G; Tonali N
Molecules; 2024 Feb; 29(3):. PubMed ID: 38338465
[TBL] [Abstract][Full Text] [Related]
16. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
17. Cell models for Alzheimer's and Parkinson's disease: At the interface of biology and drug discovery.
Cetin S; Knez D; Gobec S; Kos J; Pišlar A
Biomed Pharmacother; 2022 May; 149():112924. PubMed ID: 36068783
[TBL] [Abstract][Full Text] [Related]
18. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
Šaponjić J
Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
[TBL] [Abstract][Full Text] [Related]
19. Innovative Therapeutic Strategies in Alzheimer's Disease: A Synergistic Approach to Neurodegenerative Disorders.
Niazi SK; Magoola M; Mariam Z
Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931409
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Potential of Antidiabetic Agents as Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: A Comprehensive Review.
Koshatwar M; Acharya S; Prasad R; Lohakare T; Wanjari M; Taksande AB
Cureus; 2023 Sep; 15(9):e44763. PubMed ID: 37809189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
